Associate Professor Alexander Guminski

Associate Professor
Medicine, Northern Clinical School

Telephone 02 99265020
Fax 02 99064150

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Fogarty, G., Guminski, A., Shannon, K. (2013). How important is multidisciplinary treatment of melanoma metastases? Expert Review of Dermatology, 8(4), 339-341. [More Information]
  • Johnston, M., Guo, L., Back, M., Guminski, A., Lee, A., Hanna, C., Veivers, D., Wignall, A., Eade, T. (2013). Intensity-modulated radiotherapy using simultaneous-integrated boost for definitive treatment of locally advanced mucosal head and neck cancer: Outcomes from a single-institution series. Journal of Medical Imaging and Radiation Oncology, 57(3), 356-363. [More Information]
  • Saunders, N., Simpson, F., Thompson, E., Hill, M., Endo-Munoz, L., Leggatt, G., Minchin, R., Guminski, A. (2012). Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives. EMBO Molecular Medicine (Online), 4(8), 675-684. [More Information]
  • Guminski, A., Thompson, J. (2009). Predicting response to IL-2 therapy for metastatic melanoma. Expert Review of Anticancer Therapy: an essential contribution to decision making in cancer care, 9(11), 1571-1575. [More Information]
  • Scurr, L., Guminski, A., Chiew, Y., Balleine, R., Sharma, R., Lei, Y., Pryor, K., Wain, G., Brand, A., Byth, K., Kennedy, C., Rizos, H., Harnett, P., deFazio, A. (2008). Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian Cancer. Clinical Cancer Research, 14(21), 6924-6932. [More Information]
  • Guminski, A., Balleine, R., Chiew, Y., Webster, L., Tapner, M., Farrell, G., Harnett, P., deFazio, A. (2006). MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma. Gynecologic Oncology, 100(2), 239-246. [More Information]
  • Guminski, A., Harnett, P., deFazio, A. (2001). Carboplatin and paclitaxel interact antagonistically in a megakaryoblast cell line - a potential mechanism for paclitaxel-mediated sparing of carboplatin-induced thrombocytopenia. Cancer Chemotherapy and Pharmacology, 48(3), 229-234.
  • Guminski, A., deFazio, A., Harnett, P. (2001). New genetics and cancer chemotherapy. Today's Life Science (Australia), 13(2), 36-40.

Patents

  • deFazio, A., Harnett, P., Guminski, A. (2005). Patent Families: Determinants of sensitivity to chemotherapeutic agents. Patent No. 2005316200.

2013

  • Fogarty, G., Guminski, A., Shannon, K. (2013). How important is multidisciplinary treatment of melanoma metastases? Expert Review of Dermatology, 8(4), 339-341. [More Information]
  • Johnston, M., Guo, L., Back, M., Guminski, A., Lee, A., Hanna, C., Veivers, D., Wignall, A., Eade, T. (2013). Intensity-modulated radiotherapy using simultaneous-integrated boost for definitive treatment of locally advanced mucosal head and neck cancer: Outcomes from a single-institution series. Journal of Medical Imaging and Radiation Oncology, 57(3), 356-363. [More Information]

2012

  • Saunders, N., Simpson, F., Thompson, E., Hill, M., Endo-Munoz, L., Leggatt, G., Minchin, R., Guminski, A. (2012). Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives. EMBO Molecular Medicine (Online), 4(8), 675-684. [More Information]

2009

  • Guminski, A., Thompson, J. (2009). Predicting response to IL-2 therapy for metastatic melanoma. Expert Review of Anticancer Therapy: an essential contribution to decision making in cancer care, 9(11), 1571-1575. [More Information]

2008

  • Scurr, L., Guminski, A., Chiew, Y., Balleine, R., Sharma, R., Lei, Y., Pryor, K., Wain, G., Brand, A., Byth, K., Kennedy, C., Rizos, H., Harnett, P., deFazio, A. (2008). Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian Cancer. Clinical Cancer Research, 14(21), 6924-6932. [More Information]

2006

  • Guminski, A., Balleine, R., Chiew, Y., Webster, L., Tapner, M., Farrell, G., Harnett, P., deFazio, A. (2006). MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma. Gynecologic Oncology, 100(2), 239-246. [More Information]

2005

  • deFazio, A., Harnett, P., Guminski, A. (2005). Patent Families: Determinants of sensitivity to chemotherapeutic agents. Patent No. 2005316200.

2001

  • Guminski, A., Harnett, P., deFazio, A. (2001). Carboplatin and paclitaxel interact antagonistically in a megakaryoblast cell line - a potential mechanism for paclitaxel-mediated sparing of carboplatin-induced thrombocytopenia. Cancer Chemotherapy and Pharmacology, 48(3), 229-234.
  • Guminski, A., deFazio, A., Harnett, P. (2001). New genetics and cancer chemotherapy. Today's Life Science (Australia), 13(2), 36-40.

To update your profile click here. For support on your academic profile contact .